Company profile
InMed Pharmaceuticals
Global leader in the manufacturing and development of rare cannabinoids. Our subsidiary is Baymedica. Nasdaq: $INM
- Industry
- Biotechnology Research
- Employees
- 18
- Headquarters
- Vancouver, BC
- LinkedIn followers
- 3,778
- Office locations
- 2
InMed Pharmaceuticals company summary
InMed Pharmaceuticals is a company in the Biotechnology Research industry, headquartered in Vancouver, BC. On LinkedIn the company has around 18 employees and 3,778 followers. The company lists 2 office locations.
What technology does InMed Pharmaceuticals use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About InMed Pharmaceuticals
InMed Pharmaceuticals is a pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates targeting the CB1/CB2 receptors. InMed’s pipeline consists of three drug development programs in the treatment of Alzheimer’s, ocular and dermatological indications. Together with our subsidiary BayMedica, we are a global leader in the manufacturing, development and commercialization of products based on rare cannabinoids and their proprietary, small molecule drug analogs. For more information, visit www.inmedpharma.com. Nasdaq: INM
Where is InMed Pharmaceuticals located?
InMed Pharmaceuticals lists 2 office locations.
Compare companies similar to InMed Pharmaceuticals
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
InMed Pharmaceuticals inmedpharma.com | Biotechnology Research | 18 | - | Vancouver, BC |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about InMed Pharmaceuticals
What does InMed Pharmaceuticals do?
InMed Pharmaceuticals is a pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates targeting the CB1/CB2 receptors. InMed’s pipeline consists of three drug development programs in the treatment of Alzheimer’s, ocular and dermatological indications. Together with our subsidiary BayMedica, we are a global leader in the manufacturing, development and commercialization of products based on rare cannabinoids and their proprietary, small molecule drug analogs. For more information, visit www.inmedpharma.com. Nasdaq: INM
How many employees does InMed Pharmaceuticals have?
InMed Pharmaceuticals has around 18 employees on LinkedIn.
Where is InMed Pharmaceuticals headquartered?
InMed Pharmaceuticals is headquartered in Vancouver, BC.
Where does InMed Pharmaceuticals have offices?
InMed Pharmaceuticals lists 2 office locations, including Vancouver, BC V6C 1B4, CA; Incline Village, Nevada, US.
Build a lead list from companies like InMed Pharmaceuticals
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.